emtricitabine (commonly called ftc, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine), with trade name emtriva (formerly coviracil), is a nucleoside reverse-transcriptase inhibitor (nrti) for the prevention and treatment of hiv infection in adults and children.